Elvia Cowan is CAO & VP at Vaxcyte, Inc. (PCVX). They have made 2 open-market trades across 1 company since 2024, most recently 2026-10-05.
CIK 0001960048
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PCVX | 27,860 | $1.8M |
Shares reported on the most recent Form 4, priced at the 2026-10-07 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PCVX | SELL · 10b5-1 | 2026-10-05 | 2026-10-07 | $86.74 | $1.6M | — | — | — |
| PCVX | SELL · 10b5-1 | 2026-04-07 | 2026-04-08 | $60.00 | $180K | +3.4% | -11.6% | +1.2% |
| PCVX | SELL · 10b5-1 | 2026-03-17 | 2026-03-18 | $55.58 | $210K | +1.3% | +14.9% | -9.2% |
| PCVX | SELL | 2026-03-11 | 2026-03-11 | $58.59 | $146K | -1.2% | +7.5% | -17.3% |
| PCVX | SELL | 2025-12-23 | 2025-12-29 | $47.92 | $1.1M | -0.6% | +10.9% | +18.7% |
| PCVX | SELL · 10b5-1 | 2024-09-03 | 2024-09-05 | $107.67 | $538K | +4.7% | -2.7% | -16.6% |
| PCVX | SELL · 10b5-1 | 2024-07-16 | 2024-07-17 | $85.00 | $425K | +1.5% | -3.4% | +41.4% |
| PCVX | SELL · 10b5-1 | 2024-07-08 | 2024-07-09 | $80.00 | $400K | +0.4% | -9.4% | +33.4% |
| PCVX | SELL · 10b5-1 | 2024-03-01 | 2024-03-04 | $74.08 | $1.7M | -2.6% | -8.5% | +1.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.